General Biologicals

General Biologicals EBIT Margin

The EBIT Margin (Operating Margin) of General Biologicals (4117.TWO) as of Oct 31, 2026 is -101.22 %. In the previous year, EBIT Margin (Operating Margin) was -84.61 % — a change of 19.64% (lower).

EBIT Margin

-101.22 %

YoY

19.64%

Last updated:

EBIT Margin (Operating Margin) of General Biologicals is 2025 -101.22 % . EBIT Margin (Operating Margin) of General Biologicals was 2024 -84.61 % . It decreases by 19.64% lower compared to the previous year.

For General Biologicals, the operating (EBIT) margin of -101.2% is down versus 7.9% a few years ago.

The General Biologicals EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-25.84 TWD
Jan 1, 2019
-14.41 TWD
Jan 1, 2020
9.11 TWD
Jan 1, 2021
7.94 TWD
Jan 1, 2022
-11.03 TWD
Jan 1, 2023
-64.17 TWD
Jan 1, 2024
-84.61 TWD
Jan 1, 2025
-101.22 TWD
The General Biologicals EBIT Margin history
YEAREBIT MarginYoY
-101.22 %+19.64%
-84.61 %+31.85%
-64.17 %+481.64%
-11.03 %-238.98%
7.94 %-12.89%
9.11 %-163.24%
-14.41 %-44.24%
-25.84 %-46.30%
-48.13 %-2.71%
-49.47 %-0.26%
-49.60 %+221.32%
-15.44 %+195,987.07%
-0.01 %-60.78%
-0.02 %-56.46%
-0.05 %-438.87%
0.01 %-137.87%
-0.04 %-11.98%
-0.04 %+361.38%
-0.01 %-96.69%
-0.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

General Biologicals Stock analysis

What does General Biologicals do? General Biologicals Corp., headquartered in Baoshan, Hsinchu, Taiwan, operates in the Health Care sector, specifically within the Biotechnology industry. The company engages in research, development, manufacturing, and trading of diagnostics, pharmaceuticals, and medical supplies. Its main products include detection reagents, biological protein new drugs, P113, and medical supplies, distributed domestically and internationally. Listed on 4 July 2002, the company employs 63 people. General Biologicals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about General Biologicals stock

EBIT Margin (Operating Margin) of General Biologicals is -101.22 % in 2025.

EBIT Margin (Operating Margin) of General Biologicals changed from -84.61 % to -101.22 %, representing a 19.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) General Biologicals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s General Biologicals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — General Biologicals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — General Biologicals